|
ZNF345 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.218600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.560000E-01 |
| Normal-vs-Stage2 |
8.449800E-01 |
| Normal-vs-Stage3 |
3.400300E-03 |
| Normal-vs-Stage4 |
6.173400E-01 |
| Stage1-vs-Stage2 |
6.165600E-01 |
| Stage1-vs-Stage3 |
1.797550E-02 |
| Stage1-vs-Stage4 |
6.236400E-01 |
| Stage2-vs-Stage3 |
7.023500E-02 |
| Stage2-vs-Stage4 |
5.733200E-01 |
| Stage3-vs-Stage4 |
4.919000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.415000E-01 |
| Normal-vs-AfricanAmerican |
6.852200E-01 |
| Normal-vs-Asian |
8.145200E-01 |
| Caucasian-vs-AfricanAmerican |
2.522200E-01 |
| Caucasian-vs-Asian |
8.980800E-01 |
| AfricanAmerican-vs-Asian |
6.368800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.049000E-01 |
| Normal-vs-Female |
9.627200E-01 |
| Male-vs-Female |
4.913800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.060600E-01 |
| Normal-vs-Extreme_Weight |
8.957800E-02 |
| Normal-vs-Obese |
8.240400E-01 |
| Normal-vs-Extreme_Obese |
4.841800E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.100400E-01 |
| Normal_Weight-vs-Obese |
9.553600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.450600E-01 |
| Extreme_Weight-vs-Obese |
1.806580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.838000E-01 |
| Obese-vs-Extreme_Obese |
6.924200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.239400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.112600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.048800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.196300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.086800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.495200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.084380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.382160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.641780E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.419900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.112400E-01 |
| Normal-VS-Type2 PRCC |
1.395890E-04 |
| Normal-VS-KIRP CIMP |
9.482900E-03 |
| Normal-VS-Unclassified PRCC |
7.510600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.7337000036739E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.640510E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.239200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.636800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.415000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.697600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.881150E-01 |
| Normal-vs-N1 |
4.525000E-01 |
| Normal-vs-N2 |
4.864300E-03 |
| N0-vs-N1 |
8.756400E-01 |
| N0-vs-N2 |
1.413560E-01 |
| N1-vs-N2 |
1.898030E-01 |
|
|
